ArcticZymes Technologies 대차 대조표 상태

재무 상태 기준 확인 6/6

ArcticZymes Technologies 의 총 주주 지분은 NOK318.8M 이고 총 부채는 NOK0.0, 이는 부채 대 자기자본 비율을 0% 로 가져옵니다. 총자산과 총부채는 각각 NOK341.8M 및 NOK22.9M 입니다.

주요 정보

부채 비율

NOK 0

부채

이자 보상 비율	n/a
현금	NOK 242.12m
주식	NOK 318.82m
총 부채	NOK 22.93m
총 자산	NOK 341.75m

최근 재무 상태 업데이트

업데이트 없음

Recent updates

재무 상태 분석

단기부채: 0DRV 의 단기 자산 ( NOK280.5M )이 단기 부채( NOK17.7M ).

장기 부채: 0DRV 의 단기 자산( NOK280.5M )이 장기 부채( NOK5.2M ).

부채 대 자본 내역 및 분석

부채 수준: 0DRV 부채가 없습니다.

부채 감소: 0DRV 지난 5년간 부채가 없습니다.

부채 범위: 0DRV 은 부채가 없으므로 영업현금흐름으로 충당할 필요가 없습니다.

이자 보장: 0DRV 에는 부채가 없으므로 이자 지불에 대한 보장은 문제가 되지 않습니다.

ArcticZymes Technologies 대차 대조표 상태

재무 상태 기준 확인 6/6

주요 정보

최근 재무 상태 업데이트

Recent updates

Chief Executive Officer recently bought kr102k worth of stock

New minor risk - Profit margin trend

Investor sentiment deteriorates as stock falls 16%

Investor sentiment deteriorates as stock falls 17%

New major risk - Earnings quality

Second quarter 2024 earnings released: EPS: kr0.05 (vs kr0.11 in 2Q 2023)

Investor sentiment improves as stock rises 15%

ArcticZymes Technologies ASA Announces the Appointment of Frank Mathias as Chairman of the Board of Directors

New major risk - Earnings quality

Less than half of directors are independent

ArcticZymes Technologies ASA Announces Board Resignations

ArcticZymes Technologies ASA Announces Resignation of Edgar Koster as Board Member

Investor sentiment deteriorates as stock falls 15%

New minor risk - Share price stability

New major risk - Earnings quality

Full year 2023 earnings released: EPS: kr0.37 (vs kr0.65 in FY 2022)

Arcticzymes Technologies Asa Announces the Launch of Its First Gmp-Grade Product, San Hq

ArcticZymes Technologies ASA Launches T7 RNA Polymerase

ArcticZymes Technologies ASA, Annual General Meeting, Jun 05, 2024

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: kr0.12 (vs kr0.05 in 3Q 2022)

ArcticZymes Technologies ASA Announces DMF for SAN HQ GMP accepted by the US FDA

Second quarter 2023 earnings released: EPS: kr0.11 (vs kr0.17 in 2Q 2022)

ArcticZymes Technologies ASA Appoints Michael Akoh as Chief Executive Officer, Will Commence His Position No Later Than 1 November 2023

First quarter 2023 earnings released: EPS: kr0.10 (vs kr0.41 in 1Q 2022)

Director recently bought kr426k worth of stock

Full year 2022 earnings released: EPS: kr0.65 (vs kr0.94 in FY 2021)

Investor sentiment deteriorated over the past week

ArcticZymes Technologies Launches SAN HQ 2.0 ELISA kit

ArcticZymes Technologies ASA Appoints Darren Ellis as Chief Scientific Officer

ArcticZymes Technologies ASA to Report Q4, 2022 Results on Feb 02, 2023

No independent directors

Third quarter 2022 earnings released: EPS: kr0.05 (vs kr0.14 in 3Q 2021)

ArcticZymes Technologies ASA Announces Resignation of Volker Wedershoven as Board Member

Second quarter 2022 earnings released: EPS: kr0.17 (vs kr0.09 in 2Q 2021)

Director recently sold kr169k worth of stock

First quarter 2022 earnings released: EPS: kr0.41 (vs kr0.40 in 1Q 2021)

No independent directors

ArcticZymes Technologies ASA Provides Sales Guidance for the Year 2022

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

ArcticZymes Technologies Launches New Products

Chief Executive Officer recently sold kr11m worth of stock

Third quarter 2021 earnings released: EPS kr0.14 (vs kr0.19 in 3Q 2020)

Second quarter 2021 earnings released: EPS kr0.09 (vs kr0.44 in 2Q 2020)

Investor sentiment deteriorated over the past week

ArcticZymes Technologies ASA Launches SAN HQ 2.0

Director recently sold kr1.7m worth of stock

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS kr0.40 (vs kr0.19 in 1Q 2020)

Full year 2020 earnings released: EPS kr1.75 (vs kr0.13 loss in FY 2019)

ArcticZymes Technologies ASA to Report Q4, 2020 Results on Jan 28, 2021

Market pulls back on stock over the past week

Market pulls back on stock over the past week

ArcticZymes Technologies ASA to Report Q3, 2020 Results on Oct 22, 2020

ArcticZymes Technologies ASA to Report Q2, 2020 Results on Aug 19, 2020

재무 상태 분석

부채 대 자본 내역 및 분석

대차 대조표

건강한 기업 발견하기